Ali Amin‐Mansour

Novartis (United States) — United States

Medicine · Health Sciences

14h-index3.0kcitations59works14.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(16), Cancer Genomics and Diagnostics(15), Cancer-related molecular mechanisms research(12), Prostate Cancer Treatment and Research(11), Colorectal and Anal Carcinomas(10)

Publications59 total

INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Nature Cancer·2024· 14 citedOpen Access
Data from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Tables 1-16 from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Data from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Methods from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Tables 1-16 from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Figures from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Figure Legends from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Figures from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Figure Legends from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplemental Methods from Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> Mutations
2023Open Access
Supplementary Table 3 from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
2023Open Access
Tables S11-S12 from Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
2023Open Access
Data from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
2023Open Access
Tables S9-S10 from Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
2023Open Access
Tables S9-S10 from Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
2023Open Access
Supplementary Information from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
2023Open Access
Tables S2-S3 from Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
2023Open Access
Tables S11-S12 from Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
2023Open Access
Data from Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Eliezer M. Van Allen(44), Levi A. Garraway(39), Gad Getz(26), Scott L. Carter(26), Jason L. Hornick(20), Amaro Taylor‐Weiner(17), Mara Rosenberg(16), Suzanne George(16), Chip Stewart(15), Chandrajit P. Raut(15), Sara Seepo(15), Samira Bahl(14), George D. Demetri(14), Stacey Gabriel(14), Stefano Sioletic(14), Andrew J. Wagner(14), Aaron Chevalier(13), Adam Tracy(13), Marisa R. Nucci(13), Bradley J. Quade(13)